Abstract:e15180 Background: KNSTRN (Kinetochore-Localized Astrin-Binding) protein participates in the biological processes of chromosome alignment and segregation and is required for accurate mitosis. However, only a few researches have focused on the functional roles of KNSTRN in various cancers. Pan-cancer analysis facilitates better understanding the KNSTRN functions in tumor development and progression. Methods: In this study, RNA-Seq data of the tumor and the adjacent tissue, along with the patient information, were collected from 30 solid tumor types in TCGA database. For each tumor type, the tumor samples were stratified into High_KNSTRN (HK) or Low_KNSTRN (LK) based on the threshold of median KNSTRN expression. As an important prognostic biomarker in pan cancers, tumor mutation burdens (TMB) were evaluated between HK and LK groups. Highly and unqiuely expressed genes in each group were included for functional enrichment analysis. To further investigate the prognostic value of KNSTRN, Kaplan-Meier survival analyses were carried out based on the overall survival (OS) data. Moreover, the mutation types such as SNV, indel, CNV, and rearrangement ooccured in those tumor types were obtained from cBioPortal of Cancer Genomics platform. We also used TIMER2 database to evaluate the associations between KNSTRN expression and CAFs and CD8+ T cells infiltrating levels. Results: We found KNSTRN was significantly up-regulated in 20 cancer types and significantly down-regulated in THCA. Consistent with the previous studies, higher KNSTRN expression levels were significantly associated with shorter OS in most cancers. The most frequently detected mutations were found in MESO, SKCM and UCS. The “deep deletion” CNV was the most frequently occurred type in MESO and UCS, and the SNV mutations highly occurred in SKCM, which meant the KNSTRN mutations were quite diverse across various cancer types. In addition, KNSTRN expression and TMB were positively correlated, and the higher TMB indicated worse prognoses in 13 cancers. Highly expressed genes in the LK group mainly participated in immune response and a large family of environmental information processing pathways. Compared to highly expressed genes related pathways in HK group, KNSTRN may likely be involved in pro-tumor regulator pathways. Moreover, KNSTRN was positively correlated with immunosuppressive genes and CAFs cell infiltration levels but negatively correlated to CD8+ T cells in most cancers. Conclusions: Most of the cancers had up-regulated KNSTRN expressions compared with adjacent tissues. Higher KNSTRN expression was significantly associated with worse clinical outcomes in those cancers. Comprehensive downstream analysis revealed the underlying mechanism of KNSTRN in tumor development and its potential clinical value as a prognostic biomarker.

Exploration of the carcinogenetic and immune role of CHK1 in human cancer

Identification of Spindle and Kinetochore-Associated Family Genes As Therapeutic Targets and Prognostic Biomarkers in Pancreas Ductal Adenocarcinoma Microenvironment

Expressional and Functional Characteristics of Checkpoint Kinase 1 As a Prognostic Biomarker in Hepatocellular Carcinoma.

Functions and Inhibitors of CHK1 in Cancer Therapy

A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors

The Clinical Significance of CHEK1 in Breast Cancer: a High-Throughput Data Analysis and Immunohistochemical Study.

An Integrative Human Pan-Cancer Analysis of Cyclin-Dependent Kinase 1 (CDK1)

CDK1 Acts as a Prognostic Biomarker Associated with Immune Infiltration in Pan-Cancer, Especially in Gastrointestinal Tumors

Pan-Cancer Genetic Profiles of Mitotic DNA Integrity Checkpoint Protein Kinases

An Integrative Pan-Cancer Analysis of PBK in Human Tumors

Identification of the Prognosis Value and Potential Mechanism of Immune Checkpoints in Renal Clear Cell Carcinoma Microenvironment

Comprehensive Pan-cancer Analysis of CMPK2 as Biomarker and Prognostic Indicator for Immunotherapy

Comprehensive pan-cancer analysis of ZNF337 as a potential diagnostic, immunological, and prognostic biomarker

Phosphoproteomics Analysis Reveals a Potential Role of CHK1 in Regulation of Innate Immunity through IRF3

NCKAP1 as a prognostic and immunological biomarker: pan-cancer analysis and validation in renal clear cell carcinoma

I kappa B kinase interacting protein as a promising biomarker in pan-cancer: A multi-omics analysis

Comparative Analysis and in vitro Experiments of Signatures and Prognostic Value of Immune Checkpoint Genes in Colorectal Cancer

A multidimensional Pan-cancer analysis of CDKN1A identifies CDKN1A as an Immunological and Prognostic Biomarker

CKS1B as a potential target for prognostic assessment and intervention in pancreatic cancer and its role in abnormal proliferation and cellular phenotype through mediation of cell cycle signaling pathways

Pan-Cancer Transcriptomic Analysis Identifies PLK1 Crucial for the Tumorigenesis of Clear Cell Renal Cell Carcinoma

Pan-cancer Analysis and KNSTRN As a Potential Prognosis Biomarker